the response was achieved in cervical carcinoma of the uterus ( 17/62 , 27 % ) , endometrial carcinoma of the uterus ( 1/7 , 14 % ) , colorectal cancer ( 6/39 , 15 % ) , breast cancer ( 5/28 , 18 % ) and stomach cancer ( 4/28 , 14 % ) .
C0476089
endometrial carcinoma of the
C0042149
uterus